Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/BIOFILCHEM stock hub

NSE/BIOFILCHEM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/BIOFILCHEMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

550.4M

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/BIOFILCHEM

In the news

Latest news · NSE/BIOFILCHEM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E19.8

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC13.1

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/BIOFILCHEM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

171

Groups with data

Currency

INR

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	26
Employees Change	-21%
Employees Change Percent	-44.68
Enterprise value	INR 547M
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE829A01014
Last refreshed	2026-05-10
Market cap	INR 550.4M
Price	INR 33.99
Price currency	INR
Rev Per Employee	12,409,961.54x
Sector	Healthcare
Sic	2834
Symbol	nse/BIOFILCHEM
Website	https://www.biofilgroup.net

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.04%
EV Earnings	19.72x
EV/EBIT	17.05x
EV/EBITDA	15.31x
EV/Sales	1.7x
P/B ratio	2.58x
P/E ratio	19.85x
P/S ratio	1.71x
PE Ratio10 Y	84x
PE Ratio3 Y	115.48x
PE Ratio5 Y	138.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.94%
EBITDA Margin	11.07%
Gross margin	15.83%
Gross Profit	INR 51.1M
Gross Profit Growth	100.91%
Gross Profit Growth Q	-14.42%
Gross Profit Growth3 Y	29.78%
Gross Profit Growth5 Y	1.9%
Net Income	INR 27.7M
Net Income Growth	357.04%
Net Income Growth Q	-51.88%
Net Income Growth Years	0%
Net Income Growth3 Y	104.73%
Net Income Growth5 Y	8.98%
Pretax Margin	10.02%
Profit Margin	8.6%
Profit Per Employee	INR 1.1M
Profitable Years	16
Roa5y	2.04
Roe5y	4.51
ROIC	13.12
Roic5y	4.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-20.63%
Cagr3y	-8.38%
Cagr5y	-14.88%
EPS Growth	352.5
EPS Growth Q	-50
EPS Growth Years	0
EPS Growth3 Y	104.1
EPS Growth5 Y	8.91
Revenue Growth	-20.55x
Revenue Growth Q	-93.43x
Revenue Growth Years	0x
Revenue Growth3 Y	21.33x
Revenue Growth5 Y	4.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 3.6M
Debt	INR 200,000
Debt EBITDA	INR 0.01
Debt Equity	INR 0
Equity	INR 213M
Interest Coverage	193.2
Net Cash	INR 3.4M
Net Cash By Market Cap	INR 0.62
Net Debt EBITDA	INR -0.1
Net Debt Equity	INR -0.02
Tangible Book Value	INR 213M
Tangible Book Value Per Share	INR 12.74
WACC	5.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.84%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-20.62%
200-day SMA	37.16
3Y total return	-23.1%
50-day SMA	31.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-55.31%
All Time High	356.1
All Time High Change	-90.45%
All Time High Date	2020-12-14
All Time Low	4.05
All Time Low Change	739.26%
All Time Low Date	2019-10-25
ATR	1.74
Beta	0.28
Ch YTD	1.25
High	35
High52	57.19
High52 Date	2025-06-06
High52ch	-40.57%
Low	33.5
Low52	25.6
Low52 Date	2026-03-30
Low52ch	32.77%
Ma50ch	6.88%
Price vs 200-day SMA	-8.54%
RSI	56.77
RSI Monthly	41.24
RSI Weekly	48.65
Sharpe ratio	-0.35x
Sortino ratio	-0.46
Total Return	-0.84%
Tr YTD	1.25
Tr1m	5.3%
Tr1w	2.41%
Tr3m	-5.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 32.1M
Operating Income Growth	300.6
Operating Income Growth Q	-53.69
Operating Income Growth3 Y	81.7
Operating Income Growth5 Y	8.81
Operating margin	9.94

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,242,940%
Shares Insiders	18.47%
Shares Qo Q	-5.26%
Shares Yo Y	0.84%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	20,644.6x
Bv Per Share	12.74
Ch1m	5.3
Ch1w	2.41
Ch1y	-20.62
Ch3m	-5.29
Ch3y	-23.1
Ch5y	-55.31
Ch6m	-13.31
Change	-1.85%
Change From Open	-0.15
Close	34.63
Days Gap	-1.7
Depreciation Amortization	3,647,500
Dollar Volume	554,784.8
Earnings Date	2026-05-29
EBIT	INR 32.1M
EBITDA	INR 35.7M
EPS	INR 1.7
F Score	2
Fiscal Year End	March
Founded	1,985
Graham Number	22.51707
Graham Upside	-33.75
Income Tax	INR 4.6M
Is Primary Listing	0
Last Earnings Date	2026-02-13
Last Report Date	2025-12-31
Lynch Fair Value	INR 15.38
Lynch Upside	-54.74
Ma150	34.89
Ma150ch	-2.59%
Ma20	33.94
Ma20ch	0.16%
Next Earnings Date	2026-05-29
Open	34.04
Position In Range	32.67
Price Date	2026-05-08
Price EBITDA	INR 15.41
Ptbv Ratio	2.58
Relative Volume	0.69x
Revenue	322,659,000x
Tax By Revenue	1.43x
Tax Rate	14.26%
Tr6m	-13.31%
Volume	16,322

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/BIOFILCHEM pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/BIOFILCHEM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/BIOFILCHEM?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+18.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.8%

Negative means the company is buying back shares.

Technical

NSE/BIOFILCHEM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.8

Neutral momentum band

Price vs 200-day MA

-8.5%

50/200-day relationship not available

Beta (5Y)

0.28

Less volatile than the market

Sharpe ratio

-0.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/BIOFILCHEM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/BIOFILCHEM stock rating?

nse/BIOFILCHEM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/BIOFILCHEM analysis?

The full report lives at /stocks/nse/BIOFILCHEM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/BIOFILCHEM?

The latest report frames nse/BIOFILCHEM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/BIOFILCHEM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.